Veradigm Income from Continuous Operations 2010-2022 | MDRX
Veradigm income from continuous operations from 2010 to 2022. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Veradigm Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2022 | $-20 |
| 2021 | $128 |
| 2020 | $-28 |
| 2019 | $-238 |
| 2018 | $-43 |
| 2017 | $-185 |
| 2016 | $31 |
| 2015 | $-2 |
| 2014 | $-66 |
| 2013 | $-104 |
| 2012 | $-1 |
| 2011 | $74 |
| 2010 | $-6 |
| 2010 | $63 |
| 2009 | $26 |
| Veradigm Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2022-12-31 | $-53 |
| 2022-09-30 | $11 |
| 2022-06-30 | $3 |
| 2022-03-31 | $18 |
| 2021-12-31 | $77 |
| 2021-09-30 | $20 |
| 2021-06-30 | $26 |
| 2021-03-31 | $4 |
| 2020-12-31 | $40 |
| 2020-09-30 | $-14 |
| 2020-06-30 | $-22 |
| 2020-03-31 | $-32 |
| 2019-12-31 | $-75 |
| 2019-09-30 | $-6 |
| 2019-06-30 | $-150 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $-90 |
| 2018-09-30 | $-12 |
| 2018-06-30 | $85 |
| 2018-03-31 | $-25 |
| 2017-12-31 | $-15 |
| 2017-09-30 | $-17 |
| 2017-06-30 | $-143 |
| 2017-03-31 | $-9 |
| 2016-12-31 | $31 |
| 2016-09-30 | $0 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $2 |
| 2015-12-31 | $16 |
| 2015-09-30 | $-5 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-26 |
| 2014-06-30 | $-18 |
| 2014-03-31 | $-21 |
| 2013-12-31 | $-21 |
| 2013-09-30 | $-49 |
| 2013-06-30 | $-23 |
| 2013-03-31 | $-12 |
| 2012-12-31 | $-24 |
| 2012-09-30 | $9 |
| 2012-06-30 | $8 |
| 2012-03-31 | $6 |
| 2011-12-31 | $26 |
| 2011-09-30 | $19 |
| 2011-06-30 | $16 |
| 2011-03-31 | $13 |
| 2010-12-31 | $-6 |
| 2010-09-30 | $1 |
| 2010-06-30 | $13 |
| 2010-05-31 | |
| 2010-03-31 | $19 |
| 2010-02-28 | $18 |
| 2009-12-31 | |
| 2009-11-30 | $16 |
| 2009-09-30 | $13 |
| 2009-08-31 | $13 |
| 2009-05-31 | |
| 2009-02-28 | $13 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.525B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.530B | 60.47 |
| Tempus AI (TEM) | United States | $13.989B | 0.00 |
| Doximity (DOCS) | United States | $12.688B | 56.45 |
| Hims & Hers Health (HIMS) | United States | $10.074B | 82.54 |
| IRhythm Technologies (IRTC) | United States | $5.433B | 0.00 |
| Hinge Health (HNGE) | United States | $4.491B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.839B | 41.73 |
| Privia Health (PRVA) | United States | $2.699B | 199.91 |
| Heartflow (HTFL) | $2.367B | 0.00 | |
| Enovis (ENOV) | United States | $1.797B | 9.50 |
| 10x Genomics (TXG) | United States | $1.780B | 0.00 |
| Phreesia (PHR) | United States | $1.770B | 0.00 |
| Omnicell (OMCL) | United States | $1.544B | 29.75 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.446B | 63.10 |
| Clover Health Investments (CLOV) | United States | $1.399B | 0.00 |
| Claritev (CTEV) | United States | $1.189B | 0.00 |
| Evolent Health (EVH) | United States | $1.127B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.666B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.580B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.469B | 140.00 |
| Butterfly Network (BFLY) | United States | $0.383B | 0.00 |
| Carlsmed (CARL) | United States | $0.346B | 0.00 |
| TruBridge (TBRG) | United States | $0.307B | 53.89 |
| Outset Medical (OM) | United States | $0.252B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.231B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.219B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.203B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.156B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.148B | 0.00 |
| CareCloud (CCLD) | United States | $0.120B | 5.44 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.017B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |